Two Sigma Investments
NVCT icon

Two Sigma Investments’s Nuvectis Pharma NVCT Stock Holding History

Two Sigma Investments’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,435
Closed -$111K – 4306
2025
Q3 		$111K Buy
18,435
+300
+2% +$2.06K ﹤0.01% 3455
2025
Q2 		$135K Sell
18,135
-1,958
-10% -$17.8K ﹤0.01% 2970
2025
Q1 		$196K Buy
20,093
+1,523
+8% +$11K ﹤0.01% 2857
2024
Q4 		$100K Sell
18,570
-8,215
-31% -$51.5K ﹤0.01% 2967
2024
Q3 		$168K Buy
26,785
+13,741
+105% +$90.4K ﹤0.01% 2829
2024
Q2 		$82.6K Buy
+13,044
New +$88.7K ﹤0.01% 2842
2024
Q1 		– Sell
-22,771
Closed -$190K – 3268
2023
Q4 		$190K Buy
+22,771
New +$203K ﹤0.01% 2848

Other funds holding NVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Two Sigma Investments's NVCT Position: Q4 2025 in Review

Two Sigma Investments sold out of Nuvectis Pharma (NVCT) in Q4 2025, closing a stake of 18,435 shares — an estimated $111K sold.

Two Sigma Investments first reported a position in NVCT in Q4 2023 and held it in 7 quarters. The position peaked at $196K in Q1 2025. 48 funds tracked by Wall St. Rank hold NVCT as of Q4 2025.

  • Two Sigma Investments reported no remaining Nuvectis Pharma position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 18,435 Nuvectis Pharma shares in Q4 2025, an estimated $111K.
  • Two Sigma Investments first reported a position in Nuvectis Pharma in Q4 2023 and held it in 7 quarters.
  • Two Sigma Investments's Nuvectis Pharma position peaked at $196K in Q1 2025.
  • 48 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.